Rekah Pharmaceutical Industry Ltd (REKA) — Tangible Net Worth Ratio
Rekah Pharmaceutical Industry Ltd (REKA) has a Tangible Net Worth Ratio of 61.0% as of December 2025. This metric is calculated by deducting intangible assets (ILA56.27 Million) from net assets (ILA144.21 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Rekah Pharmaceutical Industry Ltd shareholders equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Rekah Pharmaceutical Industry Ltd Tangible Net Worth Ratio (2004–2025)
This chart shows how Rekah Pharmaceutical Industry Ltd's Tangible Net Worth Ratio has changed across 22 annual periods from 2004 to 2025. As of December 2025, the ratio stands at 61.0%, reflecting net assets of ILA144.21 Million with intangible assets of ILA56.27 Million ILA. Also explore net asset momentum of Rekah Pharmaceutical Industry Ltd to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Rekah Pharmaceutical Industry Ltd (2004–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Rekah Pharmaceutical Industry Ltd from 2004 to 2025, covering 22 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see REKA stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 61.0% | ILA144.21 Million | ILA56.27 Million | ILA423.68 Million | ▼ -1.5 pp |
| 2024 | 62.4% | ILA161.98 Million | ILA60.84 Million | ILA447.22 Million | ▼ -17.2 pp |
| 2023 | 79.6% | ILA155.59 Million | ILA31.66 Million | ILA484.72 Million | ▼ -7.6 pp |
| 2022 | 87.2% | ILA162.08 Million | ILA20.67 Million | ILA448.42 Million | ▲ +6.3 pp |
| 2021 | 81.0% | ILA173.06 Million | ILA32.97 Million | ILA437.09 Million | ▼ -16.5 pp |
| 2020 | 97.5% | ILA165.59 Million | ILA4.18 Million | ILA419.69 Million | ▼ -1.0 pp |
| 2019 | 98.4% | ILA155.22 Million | ILA2.44 Million | ILA367.11 Million | ▼ -0.1 pp |
| 2018 | 98.5% | ILA150.66 Million | ILA2.21 Million | ILA300.28 Million | ▲ +0.1 pp |
| 2017 | 98.4% | ILA144.62 Million | ILA2.33 Million | ILA294.95 Million | ▼ -0.4 pp |
| 2016 | 98.8% | ILA105.86 Million | ILA1.26 Million | ILA322.72 Million | ▼ -0.3 pp |
| 2015 | 99.2% | ILA123.66 Million | ILA1.04 Million | ILA323.82 Million | ▲ +0.9 pp |
| 2014 | 98.2% | ILA77.06 Million | ILA1.37 Million | ILA310.11 Million | ▲ +1.5 pp |
| 2013 | 96.7% | ILA79.51 Million | ILA2.61 Million | ILA303.16 Million | ▲ +0.5 pp |
| 2012 | 96.2% | ILA71.17 Million | ILA2.71 Million | ILA298.07 Million | ▲ +1.0 pp |
| 2011 | 95.2% | ILA64.00 Million | ILA3.08 Million | ILA286.99 Million | ▲ +0.7 pp |
| 2010 | 94.5% | ILA63.78 Million | ILA3.51 Million | ILA287.97 Million | ▲ +1.0 pp |
| 2009 | 93.5% | ILA64.15 Million | ILA4.17 Million | ILA278.40 Million | ▲ +1.6 pp |
| 2008 | 91.9% | ILA58.62 Million | ILA4.72 Million | ILA290.50 Million | ▼ -2.3 pp |
| 2007 | 94.2% | ILA67.10 Million | ILA3.89 Million | ILA300.96 Million | ▼ -0.4 pp |
| 2006 | 94.6% | ILA61.54 Million | ILA3.35 Million | ILA296.53 Million | ▼ -1.7 pp |
| 2005 | 96.2% | ILA58.85 Million | ILA2.22 Million | ILA267.00 Million | ▲ +3.0 pp |
| 2004 | 93.2% | ILA48.86 Million | ILA3.30 Million | ILA202.04 Million | — |